2025-06-01 2026-05-31 2026-05-31 false 10787857 Vale Medtech Consulting Limited 70229Management consultancy activities other than financial management iso4217:GBP xbrli:pure 107878572025-06-01 107878572026-05-31 107878572025-06-01 2026-05-31 10787857bus:Micro-entities2025-06-01 2026-05-31 10787857bus:AuditExempt-NoAccountantsReport2025-06-01 2026-05-31 10787857bus:FullAccounts2025-06-01 2026-05-31 10787857core:WithinOneYear2026-05-31 10787857core:AfterOneYear2026-05-31 10787857core:WithinOneYear2025-06-01 2026-05-31 10787857core:AfterOneYear2025-06-01 2026-05-31 10787857core:CurrentFinancialInstruments2026-05-31 10787857core:Non-currentFinancialInstruments2026-05-31 10787857core:CurrentFinancialInstruments2025-06-01 2026-05-31 10787857core:Non-currentFinancialInstruments2025-06-01 2026-05-31 10787857core:LandBuildings2025-06-01 2026-05-31 10787857core:FurnitureFittings2025-06-01 2026-05-31 10787857core:OfficeEquipment2025-06-01 2026-05-31 10787857core:Vehicles2025-06-01 2026-05-31 10787857core:PlantMachinery2025-06-01 2026-05-31 10787857core:OtherPropertyPlantEquipment2025-06-01 2026-05-31 10787857core:LandBuildings2026-05-31 10787857core:PlantMachinery2026-05-31 10787857core:Vehicles2026-05-31 10787857core:FurnitureFittings2026-05-31 10787857core:OfficeEquipment2026-05-31 10787857core:OtherPropertyPlantEquipment2026-05-31 10787857core:Right-of-useAssets2025-06-01 2026-05-31 10787857core:Right-of-useAssets2026-05-31 10787857core:Goodwill2025-06-01 2026-05-31 10787857core:PatentsTrademarksLicencesConcessionsSimilar2025-06-01 2026-05-31 10787857core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-06-01 2026-05-31 10787857core:OtherResidualIntangibleAssets2025-06-01 2026-05-31 10787857core:Goodwill2026-05-31 10787857core:DevelopmentCostsCapitalisedDevelopmentExpenditure2026-05-31 10787857core:PatentsTrademarksLicencesConcessionsSimilar2026-05-31 10787857core:OtherResidualIntangibleAssets2026-05-31 10787857dpl:CostSales2025-06-01 2026-05-31 10787857dpl:AdministrativeExpenses2025-06-01 2026-05-31 10787857dpl:DistributionCosts2025-06-01 2026-05-31107878572024-06-01 107878572025-05-31 107878572024-06-01 2025-05-31 10787857core:WithinOneYear2025-05-31 10787857core:AfterOneYear2025-05-31 10787857core:CurrentFinancialInstruments2025-05-31 10787857core:Non-currentFinancialInstruments2025-05-31 10787857core:LandBuildings2025-05-31 10787857core:PlantMachinery2025-05-31 10787857core:Vehicles2025-05-31 10787857core:FurnitureFittings2025-05-31 10787857core:OfficeEquipment2025-05-31 10787857core:OtherPropertyPlantEquipment2025-05-31 10787857core:Right-of-useAssets2025-05-31 10787857core:Goodwill2025-05-31 10787857core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-05-31 10787857core:PatentsTrademarksLicencesConcessionsSimilar2025-05-31 10787857core:OtherResidualIntangibleAssets2025-05-31 10787857dpl:AdministrativeExpenses2024-06-01 2025-05-3110787857bus:Director12025-06-01 2026-05-3110787857bus:PrivateLimitedCompanyLtd2025-06-01 2026-05-31
Vale Medtech Consulting Limited
Unaudited Financial Statements
for the year ended 31 May 2026
Company registration number 10787857
(England and Wales)

Company Information

For the year ended 31 May 2026
Director Harvie, Mark John

Registered office A27 Aerodrome Studios
2-8 Airfield Way
Christchurch
BH23 3TS

Registered number 10787857

Accountant Streets (Banbury) Limited
Gilmarde House
47 South Bar Street
Banbury
Oxfordshire
OX16 9AB

Balance Sheet

As at 31 May 2026
2026
2025
£
£
£
£
Fixed assets
1,440
1,354
Current assets
529,849
530,778
Prepayments and accrued income
1,097
3,934
Creditors amounts falling due within one year
(135,572)
(80,714)
Net current assets (liabilities)
395,374
453,998
Total assets less current liabilities
396,814
455,352
Accruals and deferred income
(2,018)
(1,720)
Net assets (liabilities)
394,796
453,632
Capital and reserves
394,796
453,632

Notes to the Financial Statements

1. Employees

The average number of employees during the year was 1 (2025: 1).
The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the Board of Directors on 14 August 2026 and are signed on its behalf by:

Harvie, Mark John
Harvie, Mark John
Director

Company registration number 10787857